Loading clinical trials...
Loading clinical trials...
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Conditions
Interventions
ASP0819
Placebo
Locations
24
United States
Site US10025 - Achieve Clinical Research, LLC
Birmingham, Alabama, United States
Site US10045 - TriWest Research Associates
El Cajon, California, United States
Site US10039 - Superior Research LLC
Sacramento, California, United States
Site US10003 - Artemis Inst For Clin Research
San Diego, California, United States
Site US10048 - Diablo Clinical Research Inc
Walnut Creek, California, United States
Site US10028 - Renstar Medical Research
Ocala, Florida, United States
Start Date
March 20, 2017
Primary Completion Date
February 27, 2018
Completion Date
February 27, 2018
Last Updated
October 29, 2024
NCT05901259
NCT03759522
NCT07398417
NCT07230171
NCT07186751
NCT07023523
Lead Sponsor
Astellas Pharma Global Development, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions